We dare to imagine

Australia's #1 research institute

We harness nature to tackle diseases in humans, animals and crops

Subscribe to newsletter Donate to research

IMB spin-out Protagonist Therapeutics recently announced exciting news: positive topline results from Phase 3 studies of their psoriasis drug, icotrokinra.
IMB researchers have discovered a link between the genetic risk of depression and heart disease in women
Here are some of the stings you might experience this Australian summer and what to do if you get stung

People’s choice voting is now open for the Universities Australia Shaping Australia Awards.

Cast your vote for the Infensa team in the Problem Solver category.

They are nominated for their work to improve outcomes for people who experience a heart attack or stroke, supported by an unexpected ally – the venomous Australian funnel-web spider.

Cast your vote

 

 

 

The Edge Magazine | Genetics

The latest in research and discovery

View magazine

 

Upcoming events

3rd Autoinflammatory Disease Symposium & Education Summit on Paediatric Rheumatology

21 February 2025 9:00am22 February 2025 5:00pm
Following previous meetings in 2017 (Garvan Institute) and 2022 (WEHI), the 3rd Autoinflammatory Disease Symposium will be combined with an Education Summit on Paediatric Rheumatology, in partnership with Zoe’s Angels, a non-profit organisation established to help benefit the lives of children diagnosed with juvenile rheumatic and musculoskeletal conditions.

Subscribe to our newsletter

Get the latest research straight to your inbox. 
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.

Subscribe

General enquiries

  +61 7 3346 2222
  imb@imb.uq.edu.au

Media enquiries

IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.

Support us

Donate to research
100% of donations go to the cause